Patents Assigned to Synphora AB
  • Method and compositions for local treatment of Meniere's disease, tinnitus and/or hearing loss
    Patent number: 7498360
    Abstract: A novel method and compositions for the local treatment of Meniere's disease, tinnitus and hearing loss are described. The treatment is based on the administration of a therapeutically effective amount of a prostaglandin of the F-type to the inner ear. The treatment can be either continuous or intermittent and may involve the use of pumps, gels, or slow release drug inserts.
    Type: Grant
    Filed: January 15, 2002
    Date of Patent: March 3, 2009
    Assignee: Synphora AB
    Inventors: Helge Rask-Andersen, Johan Stjernschantz
  • Method for treatment of female sexual dysfunction
    Patent number: 6562868
    Abstract: A selective EP2 or EP4 prostanoid receptor agonist can be used to treat female sexual dysfunction. Salts and esters of the agonists can also be used. Formulations comprising such agonists, salts, or esters can be in the form of a cream, gel, ointment, or solid, useful for topical administration.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: May 13, 2003
    Assignee: Synphora AB
    Inventors: Johan Stjernschantz, Bahram Resul
  • Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
    Patent number: 6495563
    Abstract: This invention is related to a method whereby scar formation in the drainage fistula and subconjunctival bleb created during and after glaucoma surgery using a prostaglandin subtype A or J.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: December 17, 2002
    Assignee: Synphora AB
    Inventors: Johan Stjernschantz, Bahram Resul
  • Method and composition for treatment of erectile dysfunction
    Patent number: 6476074
    Abstract: Compositions and methods for treatment of impotence or erectile dysfunction employ prostaglandins that are selective EP2 or EP4 prostanoid receptor agonists. The compositions can be formulated for intracavernous injection, or for transurethral or transdermal application.
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: November 5, 2002
    Assignee: Synphora AB
    Inventors: Johan Stjernschantz, Bahram Resul